Cargando…
Eculizumab treatment of atypical haemolytic uraemic syndrome: results from the largest prospective clinical trial to date
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4068163/ http://dx.doi.org/10.1186/cc13295 |
| _version_ | 1782322393198362624 |
|---|---|
| author | weekers, LE Campistol, JM Espinosa, M Gaber, AO Menne, J Minetti, E Provot, F Rondeau, E Ogawa, M Bedrosian, CL hourmant, M |
| author_facet | weekers, LE Campistol, JM Espinosa, M Gaber, AO Menne, J Minetti, E Provot, F Rondeau, E Ogawa, M Bedrosian, CL hourmant, M |
| author_sort | weekers, LE |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4068163 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-40681632014-07-03 Eculizumab treatment of atypical haemolytic uraemic syndrome: results from the largest prospective clinical trial to date weekers, LE Campistol, JM Espinosa, M Gaber, AO Menne, J Minetti, E Provot, F Rondeau, E Ogawa, M Bedrosian, CL hourmant, M Crit Care Poster Presentation BioMed Central 2014 2014-03-17 /pmc/articles/PMC4068163/ http://dx.doi.org/10.1186/cc13295 Text en Copyright © 2014 weekers et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation weekers, LE Campistol, JM Espinosa, M Gaber, AO Menne, J Minetti, E Provot, F Rondeau, E Ogawa, M Bedrosian, CL hourmant, M Eculizumab treatment of atypical haemolytic uraemic syndrome: results from the largest prospective clinical trial to date |
| title | Eculizumab treatment of atypical haemolytic uraemic syndrome: results from the largest prospective clinical trial to date |
| title_full | Eculizumab treatment of atypical haemolytic uraemic syndrome: results from the largest prospective clinical trial to date |
| title_fullStr | Eculizumab treatment of atypical haemolytic uraemic syndrome: results from the largest prospective clinical trial to date |
| title_full_unstemmed | Eculizumab treatment of atypical haemolytic uraemic syndrome: results from the largest prospective clinical trial to date |
| title_short | Eculizumab treatment of atypical haemolytic uraemic syndrome: results from the largest prospective clinical trial to date |
| title_sort | eculizumab treatment of atypical haemolytic uraemic syndrome: results from the largest prospective clinical trial to date |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4068163/ http://dx.doi.org/10.1186/cc13295 |
| work_keys_str_mv | AT weekersle eculizumabtreatmentofatypicalhaemolyticuraemicsyndromeresultsfromthelargestprospectiveclinicaltrialtodate AT campistoljm eculizumabtreatmentofatypicalhaemolyticuraemicsyndromeresultsfromthelargestprospectiveclinicaltrialtodate AT espinosam eculizumabtreatmentofatypicalhaemolyticuraemicsyndromeresultsfromthelargestprospectiveclinicaltrialtodate AT gaberao eculizumabtreatmentofatypicalhaemolyticuraemicsyndromeresultsfromthelargestprospectiveclinicaltrialtodate AT mennej eculizumabtreatmentofatypicalhaemolyticuraemicsyndromeresultsfromthelargestprospectiveclinicaltrialtodate AT minettie eculizumabtreatmentofatypicalhaemolyticuraemicsyndromeresultsfromthelargestprospectiveclinicaltrialtodate AT provotf eculizumabtreatmentofatypicalhaemolyticuraemicsyndromeresultsfromthelargestprospectiveclinicaltrialtodate AT rondeaue eculizumabtreatmentofatypicalhaemolyticuraemicsyndromeresultsfromthelargestprospectiveclinicaltrialtodate AT ogawam eculizumabtreatmentofatypicalhaemolyticuraemicsyndromeresultsfromthelargestprospectiveclinicaltrialtodate AT bedrosiancl eculizumabtreatmentofatypicalhaemolyticuraemicsyndromeresultsfromthelargestprospectiveclinicaltrialtodate AT hourmantm eculizumabtreatmentofatypicalhaemolyticuraemicsyndromeresultsfromthelargestprospectiveclinicaltrialtodate |